GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Voluntis SA (XPAR:ALVTX) » Definitions » Institutional Ownership

Voluntis (XPAR:ALVTX) Institutional Ownership : 4.56% (As of Jun. 18, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Voluntis Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Voluntis's institutional ownership is 4.56%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Voluntis's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Voluntis's Float Percentage Of Total Shares Outstanding is 0.00%.


Voluntis Institutional Ownership Historical Data

The historical data trend for Voluntis's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voluntis Institutional Ownership Chart

Voluntis Historical Data

The historical data trend for Voluntis can be seen below:

2020-12-31 2021-01-31 2021-02-28 2021-03-31 2021-04-30 2021-05-31 2021-06-30 2021-07-31 2021-08-31 2021-09-30
Institutional Ownership 4.53 3.95 3.36 4.11 4.44 4.44 4.84 4.84 4.56 4.56

Voluntis Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Voluntis (XPAR:ALVTX) Business Description

Traded in Other Exchanges
N/A
Address
58, Avenue de Wagram, Paris, FRA, 75017
Voluntis SA is engaged in developing patient-centric digital health solutions. The company offers digital solutions for diabetes, respiratory diseases, cancer, anticoagulation treatments, and haemophilia. The Company operates in a single segment: Development of therapeutic digital solutions based on its Theraxium platform.

Voluntis (XPAR:ALVTX) Headlines

No Headlines